<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JRA</journal-id>
<journal-id journal-id-type="hwp">spjra</journal-id>
<journal-id journal-id-type="nlm-ta">J Renin Angiotensin Aldosterone Syst</journal-id>
<journal-title>Journal of the Renin-Angiotensin-Aldosterone System</journal-title>
<issn pub-type="ppub">1470-3203</issn>
<issn pub-type="epub">1752-8976</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1470320311435535</article-id>
<article-id pub-id-type="publisher-id">10.1177_1470320311435535</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Angiotensin-converting enzyme I/D polymorphism is not associated with type 2 diabetes in a Chinese population</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Zhou</surname><given-names>Donghao</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311435535">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ruiter</surname><given-names>Rikje</given-names></name>
<xref ref-type="aff" rid="aff2-1470320311435535">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhang</surname><given-names>Jingling</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311435535">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhou</surname><given-names>Ming’ai</given-names></name>
<xref ref-type="aff" rid="aff3-1470320311435535">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname><given-names>Hongjun</given-names></name>
<xref ref-type="aff" rid="aff4-1470320311435535">4</xref>
<xref ref-type="aff" rid="aff5-1470320311435535">5</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname><given-names>Weidong</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311435535">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname><given-names>Shengxiang</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311435535">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1470320311435535"><label>1</label>Department of Endocrinology, Linyin People’s Hospital, China</aff>
<aff id="aff2-1470320311435535"><label>2</label>Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands</aff>
<aff id="aff3-1470320311435535"><label>3</label>Department of Immunology and Rheumatology, Linyi Hospital of Traditional Chinese Medicine, China</aff>
<aff id="aff4-1470320311435535"><label>4</label>Linyi 120 Emergency Medical Center, China</aff>
<aff id="aff5-1470320311435535"><label>5</label>Department of Endocrinology, Medicine School of Shandong University, Jinan, China</aff>
<author-notes>
<corresp id="corresp1-1470320311435535">Jingling Zhang, Department of Endocrinology, Linyi People’s Hospital, 27# Jiefang Road, Linyi 276000, China. Email: <email>jinglingzhang@126.com</email>.</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>9</month>
<year>2012</year>
</pub-date>
<volume>13</volume>
<issue>3</issue>
<fpage>372</fpage>
<lpage>378</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<sec id="section1-1470320311435535">
<title>Objective:</title>
<p>A role for the angiotensin-converting enzyme (<italic>ACE</italic>) gene has been suggested in the aetiology of type 2 diabetes (T2DM). However, results have been inconsistent. In this study, we performed a meta-analysis to further clarify the association between <italic>ACE</italic> I/D polymorphism and T2DM risk in a Chinese population.</p>
</sec>
<sec id="section2-1470320311435535">
<title>Methods:</title>
<p>PubMed, EMBASE, CNKI and Wan Fang Data were searched for eligible studies. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using a fixed-effects model or random-effects model.</p>
</sec>
<sec id="section3-1470320311435535">
<title>Results::</title>
<p>A total of 41 studies (4708 cases and 5368 controls) for the association between <italic>ACE</italic> I/D polymorphism and T2DM in a Chinese population were identified. The pooled ORs for the association between <italic>ACE</italic> I/D polymorphism and T2DM risk were not statistically significant under all genetic models (co-dominant model: <italic>DD</italic> vs. <italic>II</italic>: OR = 1.17, 95% CI 0.97–1.42 and <italic>ID</italic> vs. <italic>II</italic>: OR = 1.01, 95% CI 0.93–1.10; dominant model: OR = 1.06, 95% CI 0.94–1.19; multiplicative model: OR = 1.08, 95% CI 0.98–1.18). Although a marginally significant association was observed under a recessive model (OR = 1.17, 95% CI 1.00–1.36), robustness of this estimate could not be established under additional sensitivity analyses.</p>
</sec>
<sec id="section4-1470320311435535">
<title>Conclusions::</title>
<p>The meta-analysis presented in this study indicated that <italic>ACE</italic> I/D polymorphism may not be associated with the risk of T2DM in the Chinese population.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Angiotensin-converting enzyme gene</kwd>
<kwd>Chinese</kwd>
<kwd>meta-analysis</kwd>
<kwd>polymorphism</kwd>
<kwd>type 2 diabetes</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section5-1470320311435535" sec-type="intro">
<title>Introduction</title>
<p>Type 2 diabetes (T2DM), which is characterized by decreased production of insulin and/or insulin resistance, is now a serious disease worldwide.<sup><xref ref-type="bibr" rid="bibr1-1470320311435535">1</xref></sup> Since T2DM causes significant morbidity and mortality, it is of importance to identify and target risk factors involved in the development of T2DM. Besides conventional risk factors, genetic factors may also play key roles in the pathogenesis of T2DM. During the past decades, several candidate genes, including <italic>KCNJ11, PPARG, ENPP1, CAPN10</italic> and <italic>TCF7L2</italic>, have been suggested to influence the risk of T2DM.</p>
<p>The angiotensin-converting enzyme (ACE), as one of the key components of the renin–angiotensin system (RAS), generates the vasoconstrictor angiotensin II and degrades the vasodilator kinine.<sup><xref ref-type="bibr" rid="bibr2-1470320311435535">2</xref></sup> It has been suggested that high levels of angiotensin II may also play important roles in glucose and insulin regulation and that angiontensin II may increase the risk of insulin resistance and diabetes.<sup><xref ref-type="bibr" rid="bibr3-1470320311435535">3</xref></sup> One of the most frequently described polymorphisms in the <italic>AC</italic>E gene is the insertion or deletion (I/D) polymorphism which consists of a 287-bp fragment in intron 16. The <italic>DD</italic> genotype is associated with higher levels of circulating ACE than <italic>ID</italic> and <italic>II</italic> genotypes.<sup><xref ref-type="bibr" rid="bibr4-1470320311435535">4</xref></sup> To date, many studies have assessed the association between <italic>ACE I/D</italic> polymorphism and risk of T2DM. However, the results have been conflicting. The discrepant findings might be due to differences in statistical power, the subjects’ enrollment, and genetic and environmental factors. Two recent meta-analyses indicated that the <italic>D</italic> allele of the <italic>ACE I/D</italic> polymorphism was significantly associated with the risk of T2DM in Europeans whereas only a marginally significant association was observed in East Asians.<sup><xref ref-type="bibr" rid="bibr5-1470320311435535">5</xref>,<xref ref-type="bibr" rid="bibr6-1470320311435535">6</xref></sup> However, the marginally significant association in East Asians was not robust to different sensitivity analyses. In addition, these meta-analyses only included studies published in English, whereas numerous Chinese studies have been published in Chinese local journals. Therefore, in this study, we performed a meta-analysis of English and Chinese literature to clarify the association between <italic>ACE</italic> I/D polymorphism and the risk of T2DM in a Chinese population.</p>
</sec>
<sec id="section6-1470320311435535" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="section7-1470320311435535">
<title>Literature and search strategy</title>
<p>PubMed, EMBASE, CNKI and Wan Fang Data were searched for eligible articles. The search strategy to identify all potential studies involved use of combinations of the following key words: (‘the angiotensin-1 converting enzyme gene’ or ‘ACE’) and (‘variant’ or ‘polymorphism’) and (‘type 2 diabetes’ or ‘T2DM’ or ‘noninsulin-dependent diabetes mellitus’ or ‘NIDDM’). The reference lists of retrieved reviews and articles were hand-searched. The publication language was restricted to English or Chinese. If more than one article was published using the same study population, only the study with largest sample size was selected. The literature search was updated on 30 September 2011.</p>
</sec>
<sec id="section8-1470320311435535">
<title>Inclusion criteria and data extraction</title>
<p>Studies were included if they met the following inclusion criteria: (i) using a case–control or cohort design; (ii) evaluating the association between <italic>ACE</italic> I/D polymorphism and T2DM in the Chinese population; (iii) more than 50 cases; and (iv) providing sufficient data for the calculation of an odds ratio (OR) with 95% confidence interval (CI).</p>
<p>The following information was extracted from each study: (i) name of the first author; (ii) year of publication; (iii) region; (iv) sample size of cases and controls; (v) genotype distributions of cases and controls; and (vi) <italic>p</italic> value for the test of Hardy–Weinberg equilibrium (HWE) in controls. Two authors independently assessed the articles for compliance with the inclusion criteria; disagreement was followed by discussion until consensus was reached.</p>
</sec>
<sec id="section9-1470320311435535">
<title>Statistical analysis</title>
<p>The association between <italic>ACE</italic> I/D polymorphism and T2DM was assessed by calculating pooled ORs and 95% CIs under a co-dominant model, a dominant model, a recessive model, and a multiplicative model, respectively. The significance of the pooled ORs was determined by a <italic>Z</italic> test (<italic>p</italic> &lt; 0.05 was considered statistically significant). A <italic>Q</italic> test was performed to evaluate whether the variation was due to heterogeneity or due to chance. A random-effects model (DerSimonian–Laird method<sup><xref ref-type="bibr" rid="bibr7-1470320311435535">7</xref></sup>) or a fixed-effects model (Mantel–Haenszel method<sup><xref ref-type="bibr" rid="bibr8-1470320311435535">8</xref></sup>) was used to calculate the pooled ORs in the presence (<italic>p</italic> ≤ 0.10) or absence (<italic>p</italic> &gt; 0.10) of heterogeneity, respectively. Sensitivity analysis was performed by removing one study at a time to evaluate the stability of the results. Begg’s funnel plot, a scatter plot of effect against a measure of study size, was generated as a visual aid to detect bias or systematic heterogeneity.<sup><xref ref-type="bibr" rid="bibr9-1470320311435535">9</xref></sup> Publication bias was assessed by Egger’s test<sup><xref ref-type="bibr" rid="bibr10-1470320311435535">10</xref></sup> (<italic>p</italic> &lt; 0.05 was considered statistically significant). Data analyses were performed using STATA version 11 (StataCorp LP, College Station, Texas, USA).</p>
</sec>
</sec>
<sec id="section10-1470320311435535" sec-type="results">
<title>Results</title>
<sec id="section11-1470320311435535">
<title>Characteristics of the studies</title>
<p>The literature search identified a total of 174 potentially relevant papers. Of these, 93 papers were excluded after reading the title or abstract because of obvious irrelevance to our study aim. In addition, 16 duplicated publications and four reviews were excluded. Therefore, 61 papers met the primary inclusion criteria. However, in 10 papers genotypes deviated from HWE in controls, and in another 10 papers there were fewer than 50 cases; these 20 studies were therefore excluded as well. Consequently, a total of 41 studies (4708 cases and 5368 controls)<sup><xref ref-type="bibr" rid="bibr11-1470320311435535">11</xref><xref ref-type="bibr" rid="bibr12-1470320311435535"/><xref ref-type="bibr" rid="bibr13-1470320311435535"/><xref ref-type="bibr" rid="bibr14-1470320311435535"/><xref ref-type="bibr" rid="bibr15-1470320311435535"/><xref ref-type="bibr" rid="bibr16-1470320311435535"/><xref ref-type="bibr" rid="bibr17-1470320311435535"/><xref ref-type="bibr" rid="bibr18-1470320311435535"/><xref ref-type="bibr" rid="bibr19-1470320311435535"/><xref ref-type="bibr" rid="bibr20-1470320311435535"/><xref ref-type="bibr" rid="bibr21-1470320311435535"/><xref ref-type="bibr" rid="bibr22-1470320311435535"/><xref ref-type="bibr" rid="bibr23-1470320311435535"/><xref ref-type="bibr" rid="bibr24-1470320311435535"/><xref ref-type="bibr" rid="bibr25-1470320311435535"/><xref ref-type="bibr" rid="bibr26-1470320311435535"/><xref ref-type="bibr" rid="bibr27-1470320311435535"/><xref ref-type="bibr" rid="bibr28-1470320311435535"/><xref ref-type="bibr" rid="bibr29-1470320311435535"/><xref ref-type="bibr" rid="bibr30-1470320311435535"/><xref ref-type="bibr" rid="bibr31-1470320311435535"/><xref ref-type="bibr" rid="bibr32-1470320311435535"/><xref ref-type="bibr" rid="bibr33-1470320311435535"/><xref ref-type="bibr" rid="bibr34-1470320311435535"/><xref ref-type="bibr" rid="bibr35-1470320311435535"/><xref ref-type="bibr" rid="bibr36-1470320311435535"/><xref ref-type="bibr" rid="bibr37-1470320311435535"/><xref ref-type="bibr" rid="bibr38-1470320311435535"/><xref ref-type="bibr" rid="bibr39-1470320311435535"/><xref ref-type="bibr" rid="bibr40-1470320311435535"/><xref ref-type="bibr" rid="bibr41-1470320311435535"/><xref ref-type="bibr" rid="bibr42-1470320311435535"/><xref ref-type="bibr" rid="bibr43-1470320311435535"/><xref ref-type="bibr" rid="bibr44-1470320311435535"/><xref ref-type="bibr" rid="bibr45-1470320311435535"/><xref ref-type="bibr" rid="bibr46-1470320311435535"/><xref ref-type="bibr" rid="bibr47-1470320311435535"/><xref ref-type="bibr" rid="bibr48-1470320311435535"/><xref ref-type="bibr" rid="bibr49-1470320311435535"/><xref ref-type="bibr" rid="bibr50-1470320311435535"/>-<xref ref-type="bibr" rid="bibr51-1470320311435535">51</xref></sup> were included in the meta-analysis of the association between <italic>ACE</italic> I/D polymorphism and T2DM. The characteristics of the included studies are listed in <xref ref-type="table" rid="table1-1470320311435535">Table 1</xref>.</p>
<table-wrap id="table1-1470320311435535" position="float">
<label>Table 1.</label>
<caption>
<p>Characteristics of the studies included in the meta-analysis</p>
</caption>
<graphic alternate-form-of="table1-1470320311435535" xlink:href="10.1177_1470320311435535-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="left">Region</th>
<th align="left" colspan="2">Sample size</th>
<th align="left" colspan="6">Genotype frequency<hr/></th>
<th align="left"><italic>P</italic><sub>HWE</sub></th>
</tr>
<tr>
<th/>
<th/>
<th colspan="2"/>
<th align="left" colspan="3">Cases<hr/></th>
<th align="left" colspan="3">Controls<hr/></th>
<th/>
</tr>
<tr>
<th/>
<th/>
<th align="left">Cases</th>
<th align="left">Controls</th>
<th align="left">II</th>
<th align="left">ID</th>
<th align="left">DD</th>
<th align="left">II</th>
<th align="left">ID</th>
<th align="left">DD</th>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td>Han et al., 1997<sup><xref ref-type="bibr" rid="bibr11-1470320311435535">11</xref></sup></td>
<td>Beijing</td>
<td>80</td>
<td>50</td>
<td>28</td>
<td>34</td>
<td>18</td>
<td>19</td>
<td>18</td>
<td>13</td>
<td>0.057</td>
</tr>
<tr>
<td>He et al., 1997<sup><xref ref-type="bibr" rid="bibr12-1470320311435535">12</xref></sup></td>
<td>Beijing</td>
<td>67</td>
<td>85</td>
<td>27</td>
<td>32</td>
<td>8</td>
<td>25</td>
<td>41</td>
<td>19</td>
<td>0.779</td>
</tr>
<tr>
<td>Zhao et al., 1998<sup><xref ref-type="bibr" rid="bibr13-1470320311435535">13</xref></sup></td>
<td>Jiangsu</td>
<td>95</td>
<td>100</td>
<td>30</td>
<td>39</td>
<td>26</td>
<td>45</td>
<td>40</td>
<td>15</td>
<td>0.227</td>
</tr>
<tr>
<td>Wu et al., 1998<sup><xref ref-type="bibr" rid="bibr14-1470320311435535">14</xref></sup></td>
<td>Shanghai</td>
<td>123</td>
<td>110</td>
<td>39</td>
<td>57</td>
<td>27</td>
<td>43</td>
<td>44</td>
<td>23</td>
<td>0.070</td>
</tr>
<tr>
<td>Young et al., 1998<sup><xref ref-type="bibr" rid="bibr15-1470320311435535">15</xref></sup></td>
<td>Hong Kong</td>
<td>110</td>
<td>183</td>
<td>49</td>
<td>50</td>
<td>11</td>
<td>71</td>
<td>88</td>
<td>24</td>
<td>0.688</td>
</tr>
<tr>
<td>Duan et al., 1999<sup><xref ref-type="bibr" rid="bibr16-1470320311435535">16</xref></sup></td>
<td>Shanghai</td>
<td>79</td>
<td>52</td>
<td>31</td>
<td>38</td>
<td>10</td>
<td>20</td>
<td>23</td>
<td>9</td>
<td>0.594</td>
</tr>
<tr>
<td>Guan et al., 1999<sup><xref ref-type="bibr" rid="bibr17-1470320311435535">17</xref></sup></td>
<td>Shandong</td>
<td>57</td>
<td>48</td>
<td>23</td>
<td>24</td>
<td>10</td>
<td>13</td>
<td>24</td>
<td>11</td>
<td>0.990</td>
</tr>
<tr>
<td>Li et al., 1999<sup><xref ref-type="bibr" rid="bibr18-1470320311435535">18</xref></sup></td>
<td>Hebei</td>
<td>84</td>
<td>100</td>
<td>43</td>
<td>35</td>
<td>6</td>
<td>44</td>
<td>45</td>
<td>11</td>
<td>0.920</td>
</tr>
<tr>
<td>Liao et al., 1999<sup><xref ref-type="bibr" rid="bibr19-1470320311435535">19</xref></sup></td>
<td>Hunan</td>
<td>58</td>
<td>36</td>
<td>24</td>
<td>21</td>
<td>13</td>
<td>18</td>
<td>12</td>
<td>6</td>
<td>0.134</td>
</tr>
<tr>
<td>Shao et al., 1999<sup><xref ref-type="bibr" rid="bibr20-1470320311435535">20</xref></sup></td>
<td>Guangdong</td>
<td>54</td>
<td>155</td>
<td>29</td>
<td>18</td>
<td>7</td>
<td>53</td>
<td>71</td>
<td>31</td>
<td>0.418</td>
</tr>
<tr>
<td>Wang et al., 1999<sup><xref ref-type="bibr" rid="bibr21-1470320311435535">21</xref></sup></td>
<td>Beijing</td>
<td>274</td>
<td>242</td>
<td>107</td>
<td>121</td>
<td>46</td>
<td>99</td>
<td>104</td>
<td>39</td>
<td>0.190</td>
</tr>
<tr>
<td>Wu et al., 1999<sup><xref ref-type="bibr" rid="bibr22-1470320311435535">22</xref></sup></td>
<td>Sichuan</td>
<td>65</td>
<td>90</td>
<td>31</td>
<td>25</td>
<td>9</td>
<td>34</td>
<td>40</td>
<td>16</td>
<td>0.482</td>
</tr>
<tr>
<td>Chen et al., 2000<sup><xref ref-type="bibr" rid="bibr24-1470320311435535">24</xref></sup></td>
<td>Liaoning and Hebei</td>
<td>94</td>
<td>165</td>
<td>45</td>
<td>32</td>
<td>17</td>
<td>61</td>
<td>78</td>
<td>26</td>
<td>0.898</td>
</tr>
<tr>
<td>Gao et al., 2000<sup><xref ref-type="bibr" rid="bibr25-1470320311435535">25</xref></sup></td>
<td>Beijing</td>
<td>65</td>
<td>62</td>
<td>27</td>
<td>26</td>
<td>12</td>
<td>19</td>
<td>24</td>
<td>19</td>
<td>0.075</td>
</tr>
<tr>
<td>Gu et al., 2000<sup><xref ref-type="bibr" rid="bibr26-1470320311435535">26</xref></sup></td>
<td>Jiangsu</td>
<td>100</td>
<td>50</td>
<td>22</td>
<td>48</td>
<td>30</td>
<td>15</td>
<td>27</td>
<td>8</td>
<td>0.473</td>
</tr>
<tr>
<td>Li et al., 2000<sup><xref ref-type="bibr" rid="bibr27-1470320311435535">27</xref></sup></td>
<td>Hebei</td>
<td>95</td>
<td>100</td>
<td>37</td>
<td>46</td>
<td>12</td>
<td>44</td>
<td>45</td>
<td>11</td>
<td>0.920</td>
</tr>
<tr>
<td>Nan et al., 2000<sup><xref ref-type="bibr" rid="bibr28-1470320311435535">28</xref></sup></td>
<td>Shandong</td>
<td>53</td>
<td>64</td>
<td>28</td>
<td>19</td>
<td>6</td>
<td>25</td>
<td>28</td>
<td>11</td>
<td>0.517</td>
</tr>
<tr>
<td>Wang et al., 2000<sup><xref ref-type="bibr" rid="bibr29-1470320311435535">29</xref></sup></td>
<td>Beijing</td>
<td>60</td>
<td>66</td>
<td>20</td>
<td>28</td>
<td>12</td>
<td>25</td>
<td>30</td>
<td>11</td>
<td>0.696</td>
</tr>
<tr>
<td>Zeng et al., 2000<sup><xref ref-type="bibr" rid="bibr30-1470320311435535">30</xref></sup></td>
<td>Chongqing</td>
<td>51</td>
<td>48</td>
<td>15</td>
<td>21</td>
<td>15</td>
<td>15</td>
<td>20</td>
<td>13</td>
<td>0.252</td>
</tr>
<tr>
<td>Hsieh et al., 2000<sup><xref ref-type="bibr" rid="bibr23-1470320311435535">23</xref></sup></td>
<td>Taiwan</td>
<td>336</td>
<td>263</td>
<td>166</td>
<td>109</td>
<td>61</td>
<td>133</td>
<td>106</td>
<td>24</td>
<td>0.665</td>
</tr>
<tr>
<td>Pang et al., 2001<sup><xref ref-type="bibr" rid="bibr32-1470320311435535">32</xref></sup></td>
<td>Shanghai</td>
<td>78</td>
<td>172</td>
<td>38</td>
<td>33</td>
<td>7</td>
<td>81</td>
<td>75</td>
<td>16</td>
<td>0.820</td>
</tr>
<tr>
<td>Zhang et al., 2001<sup><xref ref-type="bibr" rid="bibr33-1470320311435535">33</xref></sup></td>
<td>Shandong</td>
<td>78</td>
<td>72</td>
<td>19</td>
<td>33</td>
<td>26</td>
<td>22</td>
<td>32</td>
<td>18</td>
<td>0.358</td>
</tr>
<tr>
<td>Thomas et al., 2001<sup><xref ref-type="bibr" rid="bibr31-1470320311435535">31</xref></sup></td>
<td>Hong Kong</td>
<td>137</td>
<td>119</td>
<td>60</td>
<td>63</td>
<td>14</td>
<td>39</td>
<td>61</td>
<td>19</td>
<td>0.231</td>
</tr>
<tr>
<td>Xian et al., 2002<sup><xref ref-type="bibr" rid="bibr36-1470320311435535">36</xref></sup></td>
<td>Guangxi</td>
<td>81</td>
<td>100</td>
<td>16</td>
<td>32</td>
<td>33</td>
<td>45</td>
<td>41</td>
<td>14</td>
<td>0.353</td>
</tr>
<tr>
<td>Xu et al., 2002<sup><xref ref-type="bibr" rid="bibr37-1470320311435535">37</xref></sup></td>
<td>Jiangsu</td>
<td>58</td>
<td>62</td>
<td>22</td>
<td>25</td>
<td>11</td>
<td>28</td>
<td>22</td>
<td>12</td>
<td>0.059</td>
</tr>
<tr>
<td>Xu et al.,2002<sup><xref ref-type="bibr" rid="bibr38-1470320311435535">38</xref></sup></td>
<td>Jiangsu</td>
<td>97</td>
<td>64</td>
<td>42</td>
<td>38</td>
<td>17</td>
<td>30</td>
<td>25</td>
<td>9</td>
<td>0.319</td>
</tr>
<tr>
<td>Lee et al., 2002<sup><xref ref-type="bibr" rid="bibr35-1470320311435535">35</xref></sup></td>
<td>Taiwan</td>
<td>711</td>
<td>750</td>
<td>325</td>
<td>307</td>
<td>79</td>
<td>350</td>
<td>322</td>
<td>78</td>
<td>0.757</td>
</tr>
<tr>
<td>Feng et al., 2002<sup><xref ref-type="bibr" rid="bibr34-1470320311435535">34</xref></sup></td>
<td>Beijing and Liaoning</td>
<td>128</td>
<td>125</td>
<td>51</td>
<td>51</td>
<td>26</td>
<td>56</td>
<td>56</td>
<td>13</td>
<td>0.856</td>
</tr>
<tr>
<td>Yang et al., 2003<sup><xref ref-type="bibr" rid="bibr39-1470320311435535">39</xref></sup></td>
<td>Jiangsu</td>
<td>71</td>
<td>183</td>
<td>30</td>
<td>27</td>
<td>14</td>
<td>59</td>
<td>83</td>
<td>41</td>
<td>0.256</td>
</tr>
<tr>
<td>Li et al., 2004<sup><xref ref-type="bibr" rid="bibr40-1470320311435535">40</xref></sup></td>
<td>Shanghai</td>
<td>80</td>
<td>87</td>
<td>23</td>
<td>35</td>
<td>22</td>
<td>37</td>
<td>36</td>
<td>14</td>
<td>0.304</td>
</tr>
<tr>
<td>Cheng et al., 2005<sup><xref ref-type="bibr" rid="bibr41-1470320311435535">41</xref></sup></td>
<td>Jiangsu</td>
<td>72</td>
<td>260</td>
<td>40</td>
<td>31</td>
<td>1</td>
<td>135</td>
<td>110</td>
<td>15</td>
<td>0.225</td>
</tr>
<tr>
<td>Liang et al., 2005<sup><xref ref-type="bibr" rid="bibr42-1470320311435535">42</xref></sup></td>
<td>Jiangsu</td>
<td>63</td>
<td>90</td>
<td>29</td>
<td>26</td>
<td>8</td>
<td>44</td>
<td>37</td>
<td>9</td>
<td>0.767</td>
</tr>
<tr>
<td>Shi et al., 2005<sup><xref ref-type="bibr" rid="bibr43-1470320311435535">43</xref></sup></td>
<td>Hubei</td>
<td>65</td>
<td>196</td>
<td>27</td>
<td>23</td>
<td>15</td>
<td>78</td>
<td>86</td>
<td>32</td>
<td>0.318</td>
</tr>
<tr>
<td>Zhong et al., 2005<sup><xref ref-type="bibr" rid="bibr44-1470320311435535">44</xref></sup></td>
<td>Guangxi</td>
<td>102</td>
<td>136</td>
<td>31</td>
<td>56</td>
<td>15</td>
<td>67</td>
<td>58</td>
<td>11</td>
<td>0.752</td>
</tr>
<tr>
<td>Cheng et al., 2006<sup><xref ref-type="bibr" rid="bibr46-1470320311435535">46</xref></sup></td>
<td>Hubei</td>
<td>101</td>
<td>62</td>
<td>37</td>
<td>46</td>
<td>18</td>
<td>25</td>
<td>25</td>
<td>12</td>
<td>0.218</td>
</tr>
<tr>
<td>Yang et al., 2006<sup><xref ref-type="bibr" rid="bibr45-1470320311435535">45</xref></sup></td>
<td>Beijing</td>
<td>209</td>
<td>221</td>
<td>81</td>
<td>88</td>
<td>40</td>
<td>90</td>
<td>109</td>
<td>22</td>
<td>0.183</td>
</tr>
<tr>
<td>Wang et al., 2007<sup><xref ref-type="bibr" rid="bibr47-1470320311435535">47</xref></sup></td>
<td>Shandong</td>
<td>64</td>
<td>67</td>
<td>22</td>
<td>35</td>
<td>7</td>
<td>26</td>
<td>30</td>
<td>11</td>
<td>0.640</td>
</tr>
<tr>
<td>Zhao et al., 2007<sup><xref ref-type="bibr" rid="bibr48-1470320311435535">48</xref></sup></td>
<td>Jilin</td>
<td>60</td>
<td>60</td>
<td>18</td>
<td>24</td>
<td>18</td>
<td>20</td>
<td>26</td>
<td>14</td>
<td>0.335</td>
</tr>
<tr>
<td>Bu et al., 2008<sup><xref ref-type="bibr" rid="bibr49-1470320311435535">49</xref></sup></td>
<td>Tianjin</td>
<td>92</td>
<td>50</td>
<td>29</td>
<td>42</td>
<td>21</td>
<td>23</td>
<td>18</td>
<td>9</td>
<td>0.122</td>
</tr>
<tr>
<td>Zhong et al., 2008<sup><xref ref-type="bibr" rid="bibr50-1470320311435535">50</xref></sup></td>
<td>Guangxi</td>
<td>54</td>
<td>136</td>
<td>16</td>
<td>30</td>
<td>8</td>
<td>67</td>
<td>58</td>
<td>11</td>
<td>0.752</td>
</tr>
<tr>
<td>Zhang et al., 2010<sup><xref ref-type="bibr" rid="bibr51-1470320311435535">51</xref></sup></td>
<td>Jiangsu</td>
<td>307</td>
<td>287</td>
<td>125</td>
<td>141</td>
<td>41</td>
<td>123</td>
<td>126</td>
<td>38</td>
<td>0.525</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1470320311435535">
<p><italic>P</italic><sub>HWE</sub>: <italic>P</italic> value for Hardy–Weinberg equilibrium test in controls.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section12-1470320311435535">
<title>Meta-analysis results</title>
<p>There was evidence of between-study heterogeneity under a homogeneous co-dominant model (DD vs. II: <italic>I</italic><sup>2</sup> = 51.1%, <italic>p</italic> for heterogeneity &lt; 0.001), a dominant model (<italic>I</italic><sup>2</sup> = 42.3%, <italic>p</italic> for heterogeneity = 0.003), a recessive model (<italic>I</italic><sup>2</sup> = 38.5%, <italic>p</italic> for heterogeneity = 0.007), and a multiplicative model (<italic>I</italic><sup>2</sup> = 57.6%, <italic>p</italic> for heterogeneity &lt; 0.001), respectively. Therefore, a random-effects model was used. No evidence of heterogeneity existed under a heterogeneous co-dominant model (<italic>I</italic><sup>2</sup> = 17.3%, <italic>p</italic> for heterogeneity = 0.171), therefore, in these analyses, a fix-effects model was used. The pooled ORs showed that there was no statistically significant association between <italic>ACE</italic> I/D polymorphism and T2DM risk under all genetic models (co-dominant model: <italic>DD</italic> vs. <italic>II</italic>: OR = 1.17, 95% CI 0.97–1.42 and <italic>ID</italic> vs. <italic>II</italic>: OR = 1.01, 95% CI 0.93–1.10; dominant model: OR = 1.06, 95% CI 0.94–1.19; multiplicative model: OR = 1.08, 95% CI 0.98–1.18, <xref ref-type="fig" rid="fig1-1470320311435535">Figure 1</xref>). A marginally significant association was observed under a recessive model (OR = 1.17, 95% CI 1.00–1.36) (<xref ref-type="table" rid="table2-1470320311435535">Table 2</xref>). Sensitivity analyses were performed by excluding each study at a time (data not shown). Results from these analyses suggested that the marginally significant association between <italic>ACE</italic> I/D polymorphism and T2DM risk was not robust.</p>
<fig id="fig1-1470320311435535" position="float">
<label>Figure 1.</label>
<caption>
<p>Forest plot of the meta-analysis of the association between <italic>ACE</italic> gene I/D polymorphism and type 2 diabetes under a multiplicative model (D vs. I).</p>
</caption>
<graphic xlink:href="10.1177_1470320311435535-fig1.tif"/>
</fig>
<table-wrap id="table2-1470320311435535" position="float">
<label>Table 2.</label>
<caption>
<p>Meta-analysis of association between ACE I/D polymorphism and risk of type 2 diabetes</p>
</caption>
<graphic alternate-form-of="table2-1470320311435535" xlink:href="10.1177_1470320311435535-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Contrasts</th>
<th align="left">OR (95% CI)</th>
<th align="left"><italic>P</italic> for <italic>Z</italic> test</th>
<th align="left"><italic>I</italic><sup>2</sup> (%)</th>
<th align="left"><italic>P</italic> for heterogeneity</th>
</tr>
</thead>
<tbody>
<tr>
<td>DD vs. II</td>
<td>1.17 (0.97–1.42)</td>
<td>0.091</td>
<td>51.1</td>
<td>&lt;0.001</td>
</tr>
<tr>
<td>ID vs. II</td>
<td>1.01 (0.93–1.10)</td>
<td>0.800</td>
<td>17.3</td>
<td>0.171</td>
</tr>
<tr>
<td>DD+ID vs. II</td>
<td>1.06 (0.94–1.19)</td>
<td>0.326</td>
<td>42.3</td>
<td>0.003</td>
</tr>
<tr>
<td>DD vs. ID+II</td>
<td>1.17 (1.00–1.36)</td>
<td>0.045</td>
<td>38.5</td>
<td>0.007</td>
</tr>
<tr>
<td>D vs. I</td>
<td>1.08 (0.98–1.18)</td>
<td>0.137</td>
<td>57.6</td>
<td>&lt;0.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1470320311435535">
<p>OR: odds ratio, CI: confidence interval.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section13-1470320311435535">
<title>Potential publication bias</title>
<p>No publication bias was detected for the association between <italic>ACE I/D</italic> polymorphism and T2DM risk under all genetic models (<italic>DD</italic> vs. <italic>II: p</italic> = 0.348, <italic>ID</italic> vs. <italic>II: p</italic> = 0.564, dominant model: <italic>p</italic> = 0.729, recessive model: <italic>p</italic> = 0.150, multiplicative model: <italic>p</italic> = 0.779).</p>
</sec>
</sec>
<sec id="section14-1470320311435535" sec-type="discussion">
<title>Discussion</title>
<p>The present meta-analysis indicated that the <italic>D</italic> allele of the <italic>ACE</italic> I/D polymorphism may not be associated with an increased risk of T2DM in the Chinese population. In our opinion, the results of our study are credible since we had sufficient statistical power. In addition, the performed sensitivity analyses as well as the absence of publication bias further confirm that an association between <italic>ACE</italic> I/D polymorphism and T2DM may not be present. However, our results are conflicting with findings from two recent meta-analyses. In these studies, a statistically significant association was described between the <italic>ACE I/D</italic> polymorphism and the risk of T2DM among East Asians and among Europeans.<sup><xref ref-type="bibr" rid="bibr5-1470320311435535">5</xref>,<xref ref-type="bibr" rid="bibr6-1470320311435535">6</xref></sup> However, the marginally significant association in East Asians was not robust to different sensitivity analyses. Moreover, we were able to include literature published in Chinese; therefore, the power of our study is larger in comparison with these two earlier published studies.</p>
<p>It is possible that the potential genetic effects on risk of complex diseases are different across various ethnic populations. In addition, the distribution of I/D polymorphism varies among different populations. In Europeans, the D allele frequency of this polymorphism<sup><xref ref-type="bibr" rid="bibr52-1470320311435535">52</xref></sup> is around 0.6 while in Chinese, the frequency of the D allele is estimated at 0.3.<sup><xref ref-type="bibr" rid="bibr53-1470320311435535">53</xref></sup> Therefore, the difference between the significant association among Europeans<sup><xref ref-type="bibr" rid="bibr5-1470320311435535">5</xref>,<xref ref-type="bibr" rid="bibr6-1470320311435535">6</xref></sup> and the null results found among Chinese may not be surprising. However, it has also been suggested that the main effects of the individual loci might be too small to be observed and that loci may contribute to the complex diseases only by their interaction with other genes.<sup><xref ref-type="bibr" rid="bibr54-1470320311435535">54</xref></sup> Thus, the effect of the I/D polymorphism on T2DM among Chinese might involve other polymorphisms of RAS genes which play important roles in the same biological pathways.<sup><xref ref-type="bibr" rid="bibr55-1470320311435535">55</xref></sup></p>
<p>The ACE enzyme plays a key role in the production of angiotensin II and in the catabolism of bradykinin. It has been described that angiotensin II promotes the development of T2DM through a number of mechanisms, including interfering with insulin signalling, pro-inflammatory effects on tissue causing endothelial dysfunction, inhibiting adipocyte differentiation and causing beta-cell dysfunction via oxidative stress.<sup><xref ref-type="bibr" rid="bibr56-1470320311435535">56</xref></sup> It is possible that <italic>ACE I/D</italic> polymorphism affects the outcome through a linkage disequilibrium with other causative genes or polymorphisms. In contrast, pharmacokinetic studies have indicated a reduction of heart disease mortality, and a reduction in progression to T2DM among patients using ACE inhibitors.<sup><xref ref-type="bibr" rid="bibr57-1470320311435535">57</xref></sup></p>
<p>Several limitations of our study should be noted: first, the present meta-analysis was based primarily on unadjusted effect estimates and potential confounding factors could not be taken into account. Second, the effect of potential gene–environment interactions could not be addressed as well in this meta-analysis.</p>
<p>In conclusion, our study indicated that the <italic>D</italic> allele of the <italic>ACE I/D</italic> polymorphism may not be associated with T2DM risk in a Chinese population. Further studies with the consideration of gene–gene and gene–environment interactions should be conducted to further investigate this association.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
<fn fn-type="conflict">
<label>Conflicts of interest</label>
<p>None declared.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1470320311435535">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wild</surname><given-names>R</given-names></name>
<name><surname>Roglic</surname><given-names>G</given-names></name>
<name><surname>Green</surname><given-names>A</given-names></name>
<etal/>
</person-group>. <article-title>Global prevalence of diabetes: estimates for the year 2000 and projections for 2030</article-title>. <source>Diabetes Care</source> <year>2004</year>; <volume>27</volume>: <fpage>1047</fpage>–<lpage>1053</lpage>.</citation>
</ref>
<ref id="bibr2-1470320311435535">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Costerousse</surname><given-names>O</given-names></name>
<name><surname>Danilov</surname><given-names>S</given-names></name>
<name><surname>Alhenc-Gelas</surname><given-names>F</given-names></name>
</person-group>. <article-title>Genetics of angiotensin I-converting enzyme</article-title>. <source>Clin Exp Hypertens</source> <year>1997</year>; <volume>19</volume>: <fpage>659</fpage>–<lpage>669</lpage>.</citation>
</ref>
<ref id="bibr3-1470320311435535">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carlsson</surname><given-names>PO</given-names></name>
<name><surname>Berne</surname><given-names>C</given-names></name>
<name><surname>Jansson</surname><given-names>L</given-names></name>
</person-group>. <article-title>Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats</article-title>. <source>Diabetologia</source> <year>1998</year>; <volume>41</volume>: <fpage>127</fpage>–<lpage>133</lpage>.</citation>
</ref>
<ref id="bibr4-1470320311435535">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rigat</surname><given-names>B</given-names></name>
<name><surname>Hubert</surname><given-names>C</given-names></name>
<name><surname>Alhenc-Gelas</surname><given-names>F</given-names></name>
<etal/>
</person-group>. <article-title>An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels</article-title>. <source>J Clin Invest</source> <year>1990</year>; <volume>86</volume>: <fpage>1343</fpage>–<lpage>1346</lpage>.</citation>
</ref>
<ref id="bibr5-1470320311435535">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Niu</surname><given-names>W</given-names></name>
<name><surname>Qi</surname><given-names>Y</given-names></name>
<name><surname>Gao</surname><given-names>P</given-names></name>
<etal/>
</person-group>. <article-title>Angiotensin converting enzyme D allele is associated with an increased risk of type 2 diabetes: evidence from a meta-analysis</article-title>. <source>Endocr J</source> <year>2010</year>; <volume>57</volume>: <fpage>431</fpage>–<lpage>438</lpage>.</citation>
</ref>
<ref id="bibr6-1470320311435535">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>JB</given-names></name>
<name><surname>Yang</surname><given-names>JK</given-names></name>
<name><surname>Lu</surname><given-names>JK</given-names></name>
<etal/>
</person-group>. <article-title>Angiotensin-converting enzyme gene polymorphism is associated with type 2 diabetes: a meta-analysis</article-title>. <source>Mol Biol Rep</source> <year>2010</year>; <volume>37</volume>: <fpage>67</fpage>–<lpage>73</lpage>.</citation>
</ref>
<ref id="bibr7-1470320311435535">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>DerSimonian</surname><given-names>R</given-names></name>
<name><surname>Laird</surname><given-names>N</given-names></name>
</person-group>. <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source> <year>1986</year>; <volume>7</volume>: <fpage>177</fpage>–<lpage>188</lpage>.</citation>
</ref>
<ref id="bibr8-1470320311435535">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mantel</surname><given-names>N</given-names></name>
<name><surname>Haenszel</surname><given-names>W</given-names></name>
</person-group>. <article-title>Statistical aspects of the analysis of data from retrospective studies of disease</article-title>. <source>J Natl Cancer Inst</source> <year>1959</year>; <volume>22</volume>: <fpage>719</fpage>–<lpage>748</lpage>.</citation>
</ref>
<ref id="bibr9-1470320311435535">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Begg</surname><given-names>CB</given-names></name>
<name><surname>Mazumdar</surname><given-names>M</given-names></name>
</person-group>. <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <year>1994</year>; <volume>50</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>.</citation>
</ref>
<ref id="bibr10-1470320311435535">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Egger</surname><given-names>M</given-names></name>
<name><surname>Davey Smith</surname><given-names>G</given-names></name>
<etal/>
</person-group>. <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <year>1997</year>; <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage>.</citation>
</ref>
<ref id="bibr11-1470320311435535">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Han</surname><given-names>XY</given-names></name>
<name><surname>Mao</surname><given-names>TS</given-names></name>
<name><surname>Wang</surname><given-names>LW</given-names></name>
<etal/>
</person-group>. <article-title>Association between angiotensin converting enzyme gene I/D polymorphism and diabetic nephropathy</article-title>. <source>Chin J Intern Med</source> <year>1997</year>; <volume>36</volume>: <fpage>41</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr12-1470320311435535">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>He</surname><given-names>JH</given-names></name>
<name><surname>Liu</surname><given-names>YW</given-names></name>
<name><surname>Qiu</surname><given-names>CC</given-names></name>
<etal/>
</person-group>. <article-title>A study on the polymorphism of angiotensin converting enzyme gene in patients with NIDDM complicated with stroke</article-title>. <source>Chin J Geriatr</source> <year>1997</year>; <volume>16</volume>: <fpage>114</fpage>–<lpage>116</lpage>.</citation>
</ref>
<ref id="bibr13-1470320311435535">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>WH</given-names></name>
<name><surname>Wang</surname><given-names>XY</given-names></name>
<name><surname>Ding</surname><given-names>GX</given-names></name>
</person-group>. <article-title>The relationship between insertion/deletion polymorphism of angiotensin converting enzyme gene and diabetic nephropathy in NIDDM patients</article-title>. <source>Acta Nanjing Med Univ</source> <year>1998</year>; <fpage>477</fpage>–<lpage>479</lpage>.</citation>
</ref>
<ref id="bibr14-1470320311435535">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>S</given-names></name>
<name><surname>Xiang</surname><given-names>K</given-names></name>
<name><surname>Weng</surname><given-names>Q</given-names></name>
<etal/>
</person-group>. <article-title>Relationship between angiotensin I converting enzyme gene polymorphism and diabetic nephropathy</article-title>. <source>Chin Med J (Engl)</source> <year>1998</year>; <volume>111</volume>: <fpage>478</fpage>–<lpage>479</lpage>.</citation>
</ref>
<ref id="bibr15-1470320311435535">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Young</surname><given-names>RP</given-names></name>
<name><surname>Chan</surname><given-names>JC</given-names></name>
<name><surname>Critchley</surname><given-names>JA</given-names></name>
<etal/>
</person-group>. <article-title>Angiotensinogen T235 and ACE insertion/deletion polymorphisms associated with albuminuria in Chinese type 2 diabetic patients</article-title>. <source>Diabetes Care</source> <year>1998</year>; <volume>21</volume>: <fpage>431</fpage>–<lpage>437</lpage>.</citation>
</ref>
<ref id="bibr16-1470320311435535">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Duan</surname><given-names>WL</given-names></name>
<name><surname>Fang</surname><given-names>JC</given-names></name>
<name><surname>Yang</surname><given-names>HM</given-names></name>
<etal/>
</person-group>. <article-title>Association between angiotensin-converting enzyme gene polymorphism and cerebral infarction in type 2 diabetic patients</article-title>. <source>Chin J Endocrinol Metab</source> <year>1999</year>; <volume>15</volume>: <fpage>156</fpage>–<lpage>159</lpage>.</citation>
</ref>
<ref id="bibr17-1470320311435535">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Guan</surname><given-names>GJ</given-names></name>
<name><surname>Wu</surname><given-names>T</given-names></name>
<name><surname>Wen</surname><given-names>RZ</given-names></name>
<etal/>
</person-group>. <article-title>The relationship between angiotensin I converting enzyme gene polymorphism and diabetes mellitus and diabetic nephropathy</article-title>. <source>Chin J Nephrol</source> <year>1999</year>; <volume>15</volume>: <fpage>365</fpage>–<lpage>367</lpage>.</citation>
</ref>
<ref id="bibr18-1470320311435535">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>Y</given-names></name>
<name><surname>Zhang</surname><given-names>YL</given-names></name>
<name><surname>Zhang</surname><given-names>JG</given-names></name>
<etal/>
</person-group>. <article-title>Relationship between angiotensin converting enzyme gene polymorphism and coronary heart disease in NIDDM patients in Hebei Province</article-title>. <source>J Hebei Med Univ</source> <year>1999</year>; <volume>20</volume>: <fpage>21</fpage>–<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr19-1470320311435535">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liao</surname><given-names>L</given-names></name>
<name><surname>Lei</surname><given-names>MX</given-names></name>
<name><surname>Han</surname><given-names>XY</given-names></name>
<etal/>
</person-group>. <article-title>Relationships between angiotensin I-converting enzyme (ACE) gene insertion/deletion polymorphism and diabetic nephropathy in type 2 diabetes mellitus patients</article-title>. <source>Chin J Diabetes</source> <year>1999</year>; <volume>7</volume>: <fpage>337</fpage>–<lpage>340</lpage>.</citation>
</ref>
<ref id="bibr20-1470320311435535">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shao</surname><given-names>YH</given-names></name>
<name><surname>Huang</surname><given-names>YW</given-names></name>
<name><surname>Chen</surname><given-names>JS</given-names></name>
<etal/>
</person-group>. <article-title>Insertion/deletion polymorphism in the angiotensin converting enzyme gene is not associated with NIDDM, but a predictor for progression of diabetic nephropathy in a Chinese population</article-title>. <source>Chin J Nephrol</source> <year>1999</year>; <volume>15</volume>: <fpage>36</fpage>–<lpage>39</lpage>.</citation>
</ref>
<ref id="bibr21-1470320311435535">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>JJ</given-names></name>
<name><surname>Pan</surname><given-names>Y</given-names></name>
<name><surname>Sun</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>Relationship between angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in Chinese type 2 diabetes mellitus</article-title>. <source>Journal of Capital University of Medical Sciences</source> <year>1999</year>; <volume>20</volume>: <fpage>174</fpage>–<lpage>177</lpage>.</citation>
</ref>
<ref id="bibr22-1470320311435535">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>HM</given-names></name>
<name><surname>Qu</surname><given-names>SL</given-names></name>
<name><surname>Deng</surname><given-names>YL</given-names></name>
<etal/>
</person-group>. <article-title>Association between angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in Chinese type 2 diabetes mellitus</article-title>. <source>Chin J Med Genet</source> <year>1999</year>; <volume>16</volume>: <fpage>408</fpage>–<lpage>409</lpage>.</citation>
</ref>
<ref id="bibr23-1470320311435535">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hsieh</surname><given-names>MC</given-names></name>
<name><surname>Lin</surname><given-names>SR</given-names></name>
<name><surname>Hsieh</surname><given-names>TJ</given-names></name>
<etal/>
</person-group>. <article-title>Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan</article-title>. <source>Nephrol Dial Transplant</source> <year>2000</year>; <volume>15</volume>: <fpage>1008</fpage>–<lpage>1013</lpage>.</citation>
</ref>
<ref id="bibr24-1470320311435535">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>SJ</given-names></name>
<name><surname>Zhou</surname><given-names>Z</given-names></name>
<name><surname>Chen</surname><given-names>MZ</given-names></name>
<etal/>
</person-group>. <article-title>DD genotype of angiotensin I converting enzyme gene polymorphism was associated with diabetic nephropathy</article-title>. <source>Basic Medical Sciences and Clinics</source> <year>2000</year>; <volume>20</volume>: <fpage>411</fpage>–<lpage>413</lpage>.</citation>
</ref>
<ref id="bibr25-1470320311435535">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gao</surname><given-names>LL</given-names></name>
<name><surname>Han</surname><given-names>XR</given-names></name>
<name><surname>Ji</surname><given-names>LN</given-names></name>
<etal/>
</person-group>. <article-title>Relationship between angiotensin converting enzyme (ACE) gene polymorphism and carotid atherosclerosis in type 2 diabetic patients</article-title>. <source>J Beijing Med Univ</source> <year>2000</year>; <volume>32</volume>: <fpage>461</fpage>–<lpage>464</lpage>.</citation>
</ref>
<ref id="bibr26-1470320311435535">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gu</surname><given-names>MF</given-names></name>
<name><surname>Deng</surname><given-names>ZX</given-names></name>
<name><surname>Tang</surname><given-names>JY</given-names></name>
</person-group>. <article-title>Relationship between angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in type 2 diabetes</article-title>. <source>Jiangsu Med J</source> <year>2000</year>; <volume>26</volume>: <fpage>169</fpage>–<lpage>171</lpage>.</citation>
</ref>
<ref id="bibr27-1470320311435535">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>Y</given-names></name>
<name><surname>Zhang</surname><given-names>YL</given-names></name>
<name><surname>Sun</surname><given-names>SQ</given-names></name>
<etal/>
</person-group>. <article-title>Relationship between angiotensin converting enzyme gene polymorphism and hypertension in type 2 diabetic mellitus patients in Hebei province</article-title>. <source>J Clin Cardiol</source> (<source>China</source>) <year>2000</year>; <volume>16</volume>: <fpage>259</fpage>–<lpage>261</lpage>.</citation>
</ref>
<ref id="bibr28-1470320311435535">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nan</surname><given-names>HR</given-names></name>
<name><surname>Wang</surname><given-names>DQ</given-names></name>
<name><surname>Xu</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>Association between angiotensin converting enzyme gene polymorphism and ischemic encephalopathy in type 2 diabetic mellitus patients</article-title>. <source>Chin J Diabetes</source> <year>2000</year>; <volume>8</volume>: <fpage>244</fpage>–<lpage>245</lpage>.</citation>
</ref>
<ref id="bibr29-1470320311435535">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>JJ</given-names></name>
<name><surname>Zhang</surname><given-names>XQ</given-names></name>
<name><surname>Yang</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>Association between angiotensin converting enzyme gene polymorphism and cerebral infarction in type 2 diabetic mellitus patients</article-title>. <source>Chin J Diabetes</source> <year>2000</year>; <volume>8</volume>: <fpage>45</fpage>–<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr30-1470320311435535">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zeng</surname><given-names>SC</given-names></name>
<name><surname>Jiang</surname><given-names>T</given-names></name>
<name><surname>Wang</surname><given-names>RP</given-names></name>
</person-group>. <article-title>The relationship between the gene polymorphism, the serum activities of angiotensin-I converting enzyme and type 2 diabetes and type 2 diabetes with hypertension</article-title>. <source>J Chongqing Med Univ</source> <year>2000</year>; <volume>25</volume>: <fpage>231</fpage>–<lpage>233</lpage>.</citation>
</ref>
<ref id="bibr31-1470320311435535">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thomas</surname><given-names>GN</given-names></name>
<name><surname>Tomlinson</surname><given-names>B</given-names></name>
<name><surname>Chan</surname><given-names>JC</given-names></name>
<etal/>
</person-group>. <article-title>Renin–angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of tne ACE insertion/deletion polymorphism with type 2 diabetes</article-title>. <source>Diabetes Care</source> <year>2001</year>; <volume>24</volume>: <fpage>356</fpage>–<lpage>361</lpage>.</citation>
</ref>
<ref id="bibr32-1470320311435535">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pang</surname><given-names>XF</given-names></name>
<name><surname>Gong</surname><given-names>YX</given-names></name>
<name><surname>Zhu</surname><given-names>LM</given-names></name>
<etal/>
</person-group>. <article-title>Association of polymorphism in angiontensin I-converitng enzyme gene with diabetes and diabetic nephropathy in elderly</article-title>. <source>Geriatr Health Care</source> <year>2001</year>; <volume>7</volume>: <fpage>94</fpage>–<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr33-1470320311435535">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>XY</given-names></name>
<name><surname>Wang</surname><given-names>DQ</given-names></name>
<name><surname>Xu</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>Association between renin–angiotensin system gene polymorphism and type 2 diabetics with stroke in China</article-title>. <source>Chin J Med Genet</source> <year>2001</year>; <volume>18</volume>: <fpage>462</fpage>–<lpage>466</lpage>.</citation>
</ref>
<ref id="bibr34-1470320311435535">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Feng</surname><given-names>Y</given-names></name>
<name><surname>Niu</surname><given-names>T</given-names></name>
<name><surname>Xu</surname><given-names>X</given-names></name>
<etal/>
</person-group>. <article-title>Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes</article-title>. <source>Diabetes</source> <year>2002</year>; <volume>51</volume>: <fpage>1986</fpage>–<lpage>1988</lpage>.</citation>
</ref>
<ref id="bibr35-1470320311435535">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>YJ</given-names></name>
<name><surname>Tsai</surname><given-names>JC</given-names></name>
</person-group>. <article-title>ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients</article-title>.<source>Diabetes Care</source> <year>2002</year>; <volume>25</volume>: <fpage>1002</fpage>–<lpage>1008</lpage>.</citation>
</ref>
<ref id="bibr36-1470320311435535">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Xian</surname><given-names>S</given-names></name>
<name><surname>Liao</surname><given-names>YH</given-names></name>
<name><surname>Luo</surname><given-names>ZJ</given-names></name>
<etal/>
</person-group>. <article-title>The relationship between angiotensin I converting enzyme gene polymorphism and type 2 diabetes with hypertension disease in Guangxi region</article-title>. <source>J Guangxi Med Univ</source> <year>2002</year>; <volume>19</volume>: <fpage>459</fpage>–<lpage>461</lpage>.</citation>
</ref>
<ref id="bibr37-1470320311435535">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Xu</surname><given-names>QF</given-names></name>
<name><surname>Zhu</surname><given-names>Y</given-names></name>
<name><surname>Ming</surname><given-names>W</given-names></name>
</person-group>. <article-title>Relationship between angiotensin-converting enzyme gene polymorphism and cardio-brain complications in patients with NIDDM</article-title>. <source>Journal of radioimmunology</source> <year>2002</year>; <volume>15</volume>: <fpage>130</fpage>–<lpage>132</lpage>.</citation>
</ref>
<ref id="bibr38-1470320311435535">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Xu</surname><given-names>L</given-names></name>
<name><surname>Deng</surname><given-names>ZX</given-names></name>
<name><surname>He</surname><given-names>RH</given-names></name>
<etal/>
</person-group>. <article-title>Association between angiotensin-converting enzyme gene polymorphism, serum ACE levels and cerebral infarction in type 2 diabetes mellitus patients</article-title>. <source>Transportation Medicine</source> <year>2002</year>; <volume>16</volume>: <fpage>14</fpage>–<lpage>18</lpage>.</citation>
</ref>
<ref id="bibr39-1470320311435535">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname><given-names>T</given-names></name>
<name><surname>Chen</surname><given-names>JW</given-names></name>
<name><surname>Zhou</surname><given-names>HW</given-names></name>
<etal/>
</person-group>. <article-title>A study for ACE gene polymorphism in Chinese type 2 diabetic nephropathy</article-title>. <source>Journal of Qiqihar Medical College</source> <year>2003</year>; <volume>24</volume>: <fpage>1086</fpage>–<lpage>1088</lpage>.</citation>
</ref>
<ref id="bibr40-1470320311435535">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>M</given-names></name>
<name><surname>Liu</surname><given-names>LM</given-names></name>
<name><surname>Zheng</surname><given-names>TS</given-names></name>
<etal/>
</person-group>. <article-title>Association between angiotensin I converting enzyme gene insertion/deletion polymorphism and type 2 diabetes nephropathy</article-title>. <source>Shanghai Med J</source> <year>2004</year>; <volume>27</volume>: <fpage>457</fpage>–<lpage>459</lpage>.</citation>
</ref>
<ref id="bibr41-1470320311435535">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>JL</given-names></name>
<name><surname>Shen</surname><given-names>MY</given-names></name>
<name><surname>Wang</surname><given-names>JS</given-names></name>
<etal/>
</person-group>. <article-title>Study on the relationship between ACE gene polymorphism and type 2 diabetes with nephropathy</article-title>. <source>MMJC</source> <year>2005</year>; <volume>7</volume>: <fpage>14</fpage>–<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr42-1470320311435535">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liang</surname><given-names>S</given-names></name>
<name><surname>Pan</surname><given-names>M</given-names></name>
<name><surname>Cheng</surname><given-names>H</given-names></name>
<etal/>
</person-group>. <article-title>Relationship of angiotensin converting enzyme and apolipoprotein E gene polymorphism with diabetic retinopathy</article-title>. <year>2005</year>; <volume>5</volume>: <fpage>1156</fpage>–<lpage>1159</lpage>.</citation>
</ref>
<ref id="bibr43-1470320311435535">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shi</surname><given-names>YJ</given-names></name>
<name><surname>Shen</surname><given-names>Y</given-names></name>
<name><surname>Jiang</surname><given-names>ZQ</given-names></name>
<etal/>
</person-group>. <article-title>Association between ACE gene polymorphism and type 2 diabetes</article-title>. <source>J Hubei Univ</source> (<source>Nat Sci</source>) <year>2005</year>; <volume>27</volume>: <fpage>177</fpage>–<lpage>179</lpage>.</citation>
</ref>
<ref id="bibr44-1470320311435535">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhong</surname><given-names>WG</given-names></name>
<name><surname>Tan</surname><given-names>JR</given-names></name>
<name><surname>He</surname><given-names>SJ</given-names></name>
</person-group>. <article-title>Associations of the polymorphisms in the renin2angiotensin system with type 2 diabetes mellitus and diabetic nephropathy</article-title>. <source>Basic and Clinical Medicine</source> <year>2005</year>; <volume>25</volume>: <fpage>416</fpage>–<lpage>450</lpage>.</citation>
</ref>
<ref id="bibr45-1470320311435535">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname><given-names>M</given-names></name>
<name><surname>Qiu</surname><given-names>CC</given-names></name>
<name><surname>Xu</surname><given-names>Q</given-names></name>
<etal/>
</person-group>. <article-title>Association of angiotensin converting enzyme gene I/D polymorphism with type 2 diabetes mellitus in Chinese population</article-title>. <source>Biomed Environ Sci</source> <year>2006</year>; <volume>19</volume>: <fpage>323</fpage>–<lpage>327</lpage>.</citation>
</ref>
<ref id="bibr46-1470320311435535">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>MR</given-names></name>
<name><surname>Zhang</surname><given-names>J</given-names></name>
<name><surname>Li</surname><given-names>Q</given-names></name>
<etal/>
</person-group>. <article-title>Association between angiotensin converting enzyme gene I/D polymorphism and type 2 diabetes mellitus</article-title>. <source>Huazhong Normal University Journal of Postgraduates</source> <year>2006</year>; <volume>13</volume>: <fpage>147</fpage>–<lpage>151</lpage>.</citation>
</ref>
<ref id="bibr47-1470320311435535">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Q</given-names></name>
<name><surname>Ma</surname><given-names>ZX</given-names></name>
<name><surname>Qiu</surname><given-names>SJ</given-names></name>
</person-group>. <article-title>Association between angiotensin converting enzyme gene I/D polymorphism and diabetic nephropathy</article-title>. <source>Shandong Med J</source> <year>2007</year>; <volume>47</volume>: <fpage>71</fpage>–<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr48-1470320311435535">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>Y</given-names></name>
<name><surname>Han Yand Han</surname><given-names>X</given-names></name>
</person-group>. <article-title>Association between ACE gene insertion/deletion polymorphism and type 2 diabetes with coronary heart disease in Jilin region</article-title>. <source>Chin J Lab Diagn</source> <year>2007</year>, <volume>11</volume>: <fpage>1451</fpage>–<lpage>1453</lpage>.</citation>
</ref>
<ref id="bibr49-1470320311435535">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bu</surname><given-names>TX</given-names></name>
<name><surname>Zhou</surname><given-names>JX</given-names></name>
<name><surname>Li</surname><given-names>X</given-names></name>
<etal/>
</person-group>. <article-title>The relationship between angiotensin I-converting enzyme gene insertion/deletion polymorphism and type 2 diabetics nephropathy</article-title>. <source>J Tianjin Med Univ</source> <year>2008</year>; <volume>14</volume>: <fpage>293</fpage>–<lpage>296</lpage>.</citation>
</ref>
<ref id="bibr50-1470320311435535">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhong</surname><given-names>WG</given-names></name>
</person-group>. <article-title>Association between ACE gene I/D polymorphism and AGT T174M polymorphism and type 2 diabetics nephropathy</article-title>. <source>J Guangxi Med Univ</source> <year>2008</year>; <volume>25</volume>: <fpage>908</fpage>–<lpage>910</lpage>.</citation>
</ref>
<ref id="bibr51-1470320311435535">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>RS</given-names></name>
<name><surname>Xu</surname><given-names>YF</given-names></name>
<name><surname>Zhu</surname><given-names>C</given-names></name>
<etal/>
</person-group>. <article-title>Polymorphismof angiotensin-converting enzyme gene and type 2 diabetes</article-title>. <source>Progress in Modern Biomedicine</source> <year>2010</year>; <volume>10</volume>: <fpage>3486</fpage>–<lpage>3488</lpage>.</citation>
</ref>
<ref id="bibr52-1470320311435535">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tiret</surname><given-names>L</given-names></name>
<name><surname>Rigat</surname><given-names>B</given-names></name>
<name><surname>Visvikis</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ace levels</article-title>. <source>Am J Hum Genet</source> <year>1992</year>; <volume>51</volume>: <fpage>197</fpage>–<lpage>205</lpage>.</citation>
</ref>
<ref id="bibr53-1470320311435535">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>EJ</given-names></name>
</person-group>. <article-title>Population genetics of the angiotensin-converting enzyme in Chinese</article-title>. <source>Br J Clin Pharmacol</source> <year>1994</year>; <volume>37</volume>: <fpage>212</fpage>–<lpage>214</lpage>.</citation>
</ref>
<ref id="bibr54-1470320311435535">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Culverhouse</surname><given-names>R</given-names></name>
<name><surname>Suarez</surname><given-names>BK</given-names></name>
<name><surname>Lin</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>A perspective on epistasis: limits of models displaying no main effect</article-title>. <source>Am J Hum Genet</source> <year>2002</year>; <volume>70</volume>: <fpage>461</fpage>–<lpage>471</lpage>.</citation>
</ref>
<ref id="bibr55-1470320311435535">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tsai</surname><given-names>CT</given-names></name>
<name><surname>Hwang</surname><given-names>JJ</given-names></name>
<name><surname>Ritchie</surname><given-names>MD</given-names></name>
<etal/>
</person-group>. <article-title>Renin–angiotensin system gene polymorphisms and coronary artery disease in a large angiographic cohort: detection of high order gene–gene interaction</article-title>. <source>Atherosclerosis</source> <year>2007</year>; <volume>195</volume>: <fpage>172</fpage>–<lpage>180</lpage>.</citation>
</ref>
<ref id="bibr56-1470320311435535">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leung</surname><given-names>PS</given-names></name>
<name><surname>Carlsson</surname><given-names>PO</given-names></name>
</person-group>. <article-title>Pancreatic islet renin angiotensin system: its novel roles in islet function and in diabetes mellitus</article-title>. <source>Pancreas</source> <year>2005</year>; <volume>30</volume>: <fpage>293</fpage>–<lpage>298</lpage>.</citation>
</ref>
<ref id="bibr57-1470320311435535">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hansson</surname><given-names>L</given-names></name>
<name><surname>Lindholm</surname><given-names>LH</given-names></name>
<name><surname>Niskanen</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial</article-title>. <source>Lancet</source> <year>1999</year>; <volume>353</volume>: <fpage>611</fpage>–<lpage>616</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>